Acutis Diagnostics Leverages SOPHiA GENETICS Technology to Create New Next Generation Sequencing Test
The New Assay Will Screen Patients for Clinical Trials and Help Increase Data Analysis for Clinical Researchers SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space
Source: finanznachrichten.de